Exicure (XCUR) Total Debt (2016 - 2024)

Exicure (XCUR) reported Total Debt of $1.0 million for Q2 2024, down 85.45% quarter-over-quarter from $6.9 million in Q4 2021.

Exicure (XCUR) Total Debt (2016 - 2024) Analysis & Trends

Exicure has reported Total Debt for 7 years, with the latest figure at $1.0 million in Q2 2024.

For the quarter ending Q2 2024, Total Debt changed N/A year-over-year to $1.0 million; the trailing twelve-month figure through Jun 2024 stood at $1.0 million (changed N/A YoY), and the FY2021 full-year result was $6.9 million, down 58.57% from the prior year.
Total Debt for Q2 2024 stood at $1.0 million, down from $6.9 million in the prior quarter.
The five-year high for Total Debt was $16.8 million in Q3 2021, with the low at $1.0 million in Q2 2024.
Historically, Total Debt has averaged $13.0 million across 3 years, with a median of $16.6 million in 2020.
Annual changes were most pronounced in 2020 — Total Debt surged 235.91% — and 2021, when it tumbled 58.57%.
Exicure's Total Debt stood at $16.6 million in 2020, then plunged by 58.57% to $6.9 million in 2021, then slumped by 85.45% to $1.0 million in 2024.
The last three Total Debt figures came in at $1.0 million (Q2 2024), $6.9 million (Q4 2021), and $16.8 million (Q3 2021), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-	-
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-	-
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn	319.10 Mn
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-	-
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-	-
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-	-
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn	-
9	Abivax	94.37 Bn	94.37 Bn	-	-
10	Exicure	19.38 Mn	16.77 Mn	-	-

Download Data